IDF2022-0602 Metformin or SGLT2 inhibitor as 1st line treatment of type 2 diabetes? Design and interim results of the SMARTEST trial
Diabetes Research and Clinical Practice(2023)
关键词
sglt2 inhibitor,metformin,diabetes,1st line treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要